Position in AMGN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$137,925,903
+$24,663,879 QoQ
Shares Held
392,002
+13.3% QoQ
Ownership
0.073%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026NATIXIS ADVISORS, LLC holds $2,890,133,285 across 14 Drug Manufacturers - General names. AMGN ranks #7 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
780,730 | $718,092,031 | |
| 2 | JNJ |
Johnson & Johnson
|
1,744,076 | $426,321,937 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,970,290 | $357,296,184 | |
| 4 | NVS |
Novartis AG
|
2,236,156 | $341,572,828 | |
| 5 | ABBV |
AbbVie Inc.
|
1,313,168 | $285,600,908 | |
| 6 | AZN |
Astrazeneca PLC
|
1,312,499 | $258,851,052 | |
| 7 | AMGN |
Amgen Inc
This page
|
392,002 | $137,925,903 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
951,907 | $132,667,278 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $137,925,903 | 392,002 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $113,262,024 | 346,039 | Shares | Other | 2026-02-10 | |
| 2025-09-30 | $96,246,285 | 341,057 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $94,555,583 | 338,654 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $101,145,642 | 324,653 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $73,387,622 | 281,567 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $94,318,600 | 292,724 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $86,746,118 | 277,632 | Shares | Defined | 2024-08-01 | |
| 2024-03-31 | $70,269,688 | 247,150 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $71,955,172 | 249,827 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $62,563,027 | 232,784 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $44,405,776 | 200,008 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $49,647,230 | 205,366 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $52,207,841 | 198,781 | Shares | Defined | 2023-01-27 | |
| 2022-09-30 | $43,004,066 | 190,790 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $47,527,195 | 195,344 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $40,600,852 | 167,897 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $33,614,117 | 149,416 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $29,396,310 | 138,238 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $37,806,600 | 155,104 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $38,128,888 | 153,245 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $33,041,573 | 143,709 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $43,673,583 | 171,835 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $43,610,277 | 184,899 | Shares | Other | 2020-08-11 | |
| 2020-03-31 | $68,898,398 | 339,853 | Shares | Other | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||